Business
ABATTIS ANNOUNCES GRANT OF STOCK OPTIONS
ABATTIS ANNOUNCES GRANT OF STOCK OPTIONS.
About this update from Abattis Bioceuticals Corp
[{"type":"text","content":"Vancouver, BC – July 22, 2014 - Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), the Company is pleased to announce that, in compliance with the Company's option plan, the Company has granted 2,438,100 incentive stock options to certain of its directors, officers and consultants, with each option being exercisable into a common share of Abattis at $0.64 per share for a period of five years.About Abattis Bioceuticals Corp.Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The Company is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions, by supplying and partnering with companies to employ its mass cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. The Company also has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions. For more information, visit the Company's website at: www.abattis.com.ON BEHALF OF THE BOARD\"Mike Withrow\"Michael Withrow, President & CEOFor further information, contact the Company's CEO, Michael Withrow at (778) 896-6536 or at [email protected] THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY ORACCURACY OF THIS RELEASE.FORWARD LOOKING INFORMATIONThis press release contains forward-looking statements. The use of any of the words \"anticipate\", \"continue\", \"estimate\", \"expect\", \"may\", \"will\", \"project\", \"should\", \"believe\" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statement...